Related Experiment Video

Updated: Jun 23, 2026

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

Image-based determination of 'physiomarkers' for personalized cancer therapy

Ananth Annapragada, Ravi V Bellamkonda

    Future Oncology (London, England)
    |May 20, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
    07:32

    Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

    Published on: April 12, 2024

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
    10:37

    A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

    Published on: August 22, 2025

    Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
    07:32

    Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

    Published on: April 12, 2024

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Microglia-Specific Molecular Magnetic Resonance Imaging Probe Enables Noninvasive Separation of Parkinsonian Mice from Controls.

    bioRxiv : the preprint server for biology·2026

    Fluorescence Imaging of DMDG-ICG Across NIR-I and NIR-II Windows Using a Single-Camera System.

    International journal of molecular sciences·2026

    Alzheimer's Imaging Consortium.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    A dual target molecular magnetic resonance imaging probe for noninvasive profiling of pathologic alpha-synuclein and microgliosis in a mouse model of Parkinson's disease.

    Frontiers in neuroscience·2024

    Stratification of Pediatric COVID-19 Cases Using Inflammatory Biomarker Profiling and Machine Learning.

    Journal of clinical medicine·2023

    The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies.

    Journal of the National Cancer Institute·2023

    DESTINY-Lung06: trastuzumab deruxtecan and pembrolizumab as first-line treatment for HER2-overexpressing, PD-L1 TPS <50% NSCLC.

    Future oncology (London, England)·2026

    The ongoing first-line treatment race for metastatic pancreatic ductal adenocarcinomas: will a tough disease lose its horror?

    Future oncology (London, England)·2026

    Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial.

    Future oncology (London, England)·2026

    PSMA-PET/mpMRI-guided focal dose-escalated stereotactic body radiotherapy for localized prostate cancer: study protocol for a prospective, randomized controlled trial.

    Future oncology (London, England)·2026

    Prognostic disparities between radioactive iodine-refractory and non-refractory DTC patients: a cohort study on survival rates and independent risk factors.

    Future oncology (London, England)·2026

    Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences.

    Future oncology (London, England)·2026

    A CECT-Based 2PI System as a Novel Noninvasive Prognostic Tool for Hepatocellular Carcinoma: A Dual-Validation Study.

    Cancer science·2026

    AI-Driven Rational Design of Nanotherapeutics for Pancreatic Ductal Adenocarcinoma.

    Medicinal research reviews·2026

    Diagnosis of ovarian cancer using multiple biomarkers of CA 125, CA153, CA 19-9, CEA, HE4 and ROMA index.

    Annales de biologie clinique·2026

    Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma and Its Association with Pathological Grade and Stage.

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026

    Cribriform Growth in Gleason Score 7 Prostatic Adenocarcinoma and Its Association with Pathological Parameters.

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026

    A Technique for the Generation of Mucosal and Acral Melanoma Cell Lines.

    Pigment cell & melanoma research·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us